Heather DiLallo honored by St Mary's College

Author: Marya Lieberman

The 2019 Lumen Christi award was presented to Heather DiLallo, who has worked for many years with the PAD project at Saint Mary's. Heather is a Chemistry major who has worked to detect falsified medicines in Nepal and China through Toni Barstis's IRES program.  She is in the 5-year dual degree program, and will be continuing her engineering coursework next academic year at Notre Dame.  We look forward to seeing her around campus! …

Read More

Good Guy Tom's

Author: Marya Lieberman

I'm at the icddr,b site in Bandarban, and sharing the facility with about 800 boxes of shoes donated by shoe company Tom's.  They promise that for every pair they sell in the US, they'll donate a pair of shoes to children in need.  Looks like they are following through.  The community health workers distribute the shoes when they're doing their other duties.  Photo coming later. …

Read More

PADs in Bangladesh

Author: Marya Lieberman

Marya Lieberman gave a workshop about post-market surveillance for 40 staff members from the Directorate General of Drug Administration in Dhaka, Bangladesh, the National Control Lab, and WHO-PQM. 

The workshop included a fun project to evaluate the supply chain of a medicine which involved 28 neophytes analyzing samples from a fictional country.  The PAD reader box also made its first debut outside Notre Dame.  This smart PAD reader will be sited in Bandarban at the icddr,b field office, where a small sampling project will be based in 2019.    …

Read More

Policy actions against falsified and substandard medicine

Author: Marya Lieberman

ASTMH Journal has a good review of policy options for combatting  falsified and substandard medicines--link here. 

Abstract:  Falsified and substandard medicines are associated with tens of thousands of deaths, mainly in young children in poor countries. Poor-quality drugs exact an annual economic toll of up to US$200 billion and contribute to the increasing peril of antimicrobial resistance. The WHO has emerged recently as the global leader in the battle against poor-quality drugs, and pharmaceutical companies have increased their roles in assuring the integrity of drug supply chains. Despite advances in drug quality surveillance and detection technology, more efforts are urgently required in research, policy, and field monitoring to halt the pandemic of bad drugs. In addition to strengthening international and national pharmaceutical governance, in part by national implementation of the Model Law on Medicines and Crime, a quantifiable Sustainable Development Goal target and an international convention to insure drug quality and safety are urgent priorities.…

Read More

Thank you to USP!

Author: Marya Lieberman

In analytical chemistry, everything depends on access to high quality reference materials. The US Pharmacopeia donated over $5,000 worth of reference standards to the PAD project in 2019.  Thanks for this contribution to our work! 

Read More

Oxford conference on Medicine Quality and Public Health

Author: Marya Lieberman

The Medicine Quality and Public Health conference at Oxford University had 200 participants from over 50 countries, including the Directors General of the Tanzanian and Nigerian drug regulatory agencies and academics, NGOs, WHO, and pharmaceutical companies.

Marya Lieberman and Philip Coyne attended and gave several presentations.  …

Read More

Cartoon version of PAD project at MQPH meeting

Author: Marya Lieberman

At the Oxford MQPH conference, Marya Lieberman presented in a session titled Screening Technologies:  Will they Save the Day?  The talk was captured by the sketch artist.  Here we see a summary of how the PAD works and the results of the supply chain exercise that the 20 students in the short course obtained the previous week.  …

Read More

NSF awards funding for studying supply chains for illicit pharmaceuticals

Author: Marya Lieberman

The National Science Foundation has awarded our team an exploratory grant to use PADs to detect and dismantle supply chains for bad quality pharmaceuticals.  We will work with Professor Karen Smilowitz at Northwestern,  who studies logistics and management of health care systems, and with three international partners.  Dr. Mercy Maina is a pharmacist at the Moi Teaching and Referral Hospital in Eldoret, Kenya who has a long standing interest in pharmaceutical supply chains, pharmacovigilence, and quality management;  Dr. Wasif Ali Khan is a research scientist at the Institute for the study of Diarrheal Diseases, Bangladesh, which has research centers in rural Bangladesh where the bulk of the population lives, and Mr. Ibrahim Chikowe is an instructor in the College of Medicine, University of Malawi. …

Read More

Blockchain Working Group awards grant to PAD project

Author: Marya Lieberman

Our proposal titled "The whole world is watching:  tracking bad quality medicine with citizen science and an electronic ledger" was funded by the Notre Dame Blockchain Working Group for 2018!  Computer scientists James and Chris Sweet will work with the PAD project to institute a distributed electronic ledger that can track test results for particular products.  We look forward to using this new methodology for determining the reliability of different actors in the pharmaceutical supply chain.  …

Read More

PAD patent licensed to Veripad LLC

Author: Marya Lieberman

Notre Dame has licensed the PAD technology to Veripad, LLC.  This startup company has developed a cell-phone based PAD reader that automatically analyzes the PAD image for the user.  Watch for more developments!  

Veripad GrabVeripad's mobile application reads the result from the PAD test…

Read More

PADs on PBS Newshour

Author: Marya Lieberman

PBS Newshour for Dec. 14 included an 8 min segment on falsified and substandard medicines in Kenya.  Mercy Maina  (Pharmacist at Moi Teaching and Referral Hospital) appears on this segment to demo some PADs and discuss the public health problems caused by falsified antibiotics.  Congrats on the coverage!  …

Read More

Saving Lives at Birth

Author: Marya Lieberman

We're excited to be named as a finalist for the Round 7 Saving Lives at Birth seed award.  Our innovation wll help birth attendants to treat bleeding after childbirth with high quality medicines that can save lives.

Read More

Veripad selected for 2017 Mass Challenge Accelerator program

Author: Marya Lieberman

PAD commercialization takes another step towards reality.   Veripad joins 127 other startup companies in this prestigious startup accelerator's 2017 class.  Over 5,000 applications were evaluated.  In addition to support and mentoring, the team will have access to a premium makerspace and research lab that will be a great starting point for manufacturing prototyping and lane chemistry development.  …

Read More